483
Mid-Continent Packaging, IncFDA 483 - Mid-Continent Packaging, Inc - March 07, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Mid-Continent Packaging, Inc. in Enid, OK, an OTC drug manufacturer, revealed a significant quality control issue. The firm failed to determine actual and theoretical yield percentages at the conclusion of each manufacturing phase, instead performing these calculations months after product distribution. This practice led to delayed identification of significant yield discrepancies, indicating a breakdown in process control and record-keeping.
Open in Dashboard
ID · d374b435-7586-4cb3-8e8d-ad12f1695d63